Latest / Stock Movers / Humana Sinks; Ford Climbs; Biogen Beat
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio News.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: Let's take a look at some stocks on the move now.
- 0:17Speaker 1: I'm Nathan Hager, joined by Bloomberg's Dan Curtis. Before we
- 0:21Speaker 1: get to Meta and Microsoft, I think those gonna be
- 0:24Speaker 1: the big earning stories this afternoon.
- 0:25Speaker 3: Dan, we got earnings this morning.
- 0:27Speaker 1: From a couple of names in the health space, starting
- 0:31Speaker 1: off with q MANA.
- 0:32Speaker 3: How they do.
- 0:33Speaker 4: Good morning, Good morning, Nathan. Shares aren't doing that well
- 0:36Speaker 4: in the pre market. They are down over seven percent
- 0:39Speaker 4: underticker HUM. The company's maintaining its yearly profit guidance despite
- 0:44Speaker 4: a stronger than expected second quarter, so that shows that
- 0:47Speaker 4: shows softness in the second half of the year. We
- 0:49Speaker 4: got to beat in the second quarter, but not enough
- 0:51Speaker 4: to raise the follier guidance, and we're seeing that reflected
- 0:54Speaker 4: in the third quarter outlook. Company is saying it's adjusted
- 0:57Speaker 4: loss per share will be one dollar in that period.
- 1:01Speaker 4: The company has been outperforming recently though, up over fifty
- 1:05Speaker 4: percent year to date, and it gets a bulk of
- 1:08Speaker 4: its sales from the medicare advantage plan. So this stock
- 1:11Speaker 4: has been relatively volatile. It's had a massive run up
- 1:14Speaker 4: into these earnings, some of that profit getting taken out
- 1:16Speaker 4: in the pre market.
- 1:17Speaker 1: The STOPWRLL looks like we got a better earning story
- 1:19Speaker 1: from the biotech Biogen.
- 1:24Speaker 3: Is that stock seeing a lift.
- 1:26Speaker 4: It's almost flat in the pre market. It's down about
- 1:29Speaker 4: three tenths of a percent. But yeah, as you said,
- 1:32Speaker 4: that's relatively better than seven percent down for humanas so yep,
- 1:35Speaker 4: on a comparable basis, it's better. The biotech company beat
- 1:39Speaker 4: top and bottom line estimates. It benefited from newly acquired
- 1:42Speaker 4: kidney and eye disease drugs that helped offset falling revenue
- 1:46Speaker 4: from multiple sclerosis medicines, and the company raised its revenue.
- 1:51Speaker 3: Outlook for the year.
- 1:52Speaker 4: It's forecasting a gain when previously previous guidance was for
- 1:56Speaker 4: a slip in revenue growth. However, the company is low
- 2:00Speaker 4: or its adjusted earnings forecast on expected charges for acquired
- 2:03Speaker 4: R and D and financing costs related to its May
- 2:06Speaker 4: acquisition of a Palace pharmaceutical So that's probably what's winging
- 2:09Speaker 4: on shares a bit this morning. And the company has
- 2:11Speaker 4: taken an aggressive acquisition strategy, and Juna announced another deal
- 2:15Speaker 4: to acquire immunology drug company raise Thera for up to
- 2:17Speaker 4: a billion dollars, So some of those costs eating into
- 2:20Speaker 4: the earnings, so the company sees so the shares are
- 2:22Speaker 4: about flat in pre marketing.
- 2:24Speaker 1: Okay, well, let's get to some stocks that reported earnings
- 2:26Speaker 1: after they close yesterday. Pretty strong results looks like from Ford.
- 2:30Speaker 4: Yeah, and this is the stock is up nearly five
- 2:33Speaker 4: percent in the pre market ticker F. The company is
- 2:36Speaker 4: raising its profit outlook for the second time this year,
- 2:39Speaker 4: and second quarter earnings topped estimates despite a revenue miss,
- 2:42Speaker 4: and that kind of points to what's going on with
- 2:45Speaker 4: the company. They are seeing high demand for SUVs, which
- 2:49Speaker 4: carry high margins, one of the reasons why revenue was
- 2:51Speaker 4: not quite as strong as expected, but earnings carried in
- 2:54Speaker 4: a beat. And this follows a similar move by GM
- 2:57Speaker 4: last week. So we're seeing a lot of demand in
- 2:59Speaker 4: the US car market for these SUVs as these companies
- 3:03Speaker 4: capitalize on the Trump administration's move to slash fuel efficiency requirements,
- 3:08Speaker 4: and the models are helping to fat in the bottom line.
- 3:10Speaker 4: Ford itself is looking to invest two billion dollars into
- 3:13Speaker 4: a new energy storage business, which could take years to
- 3:15Speaker 4: turn a profit, so these fatter margins helping the company
- 3:18Speaker 4: through the s earning season.
- 3:19Speaker 1: All right, can't let you go without an update on
- 3:21Speaker 1: sk Heinich. Some disappointment there for sure.
- 3:24Speaker 3: Yeah, so I'm watching the ADRs right now.
- 3:26Speaker 4: They're down about two percent in the pre market SKHY
- 3:29Speaker 4: and this company has been all over the place overnight.
- 3:32Speaker 4: The Korean memory company posted three core revenue growth of
- 3:34Speaker 4: over two hundred and fifty percent, but that fell short
- 3:37Speaker 4: of the target. The company also ear mark thirty one
- 3:39Speaker 4: billion dollars in capital spending, which is a fifty percent increase,
- 3:43Speaker 4: so overall a very volatile stock.
- 3:44Speaker 2: To watch this stock movers report from Bloomberg Radio. Check
- 3:49Speaker 2: back with us throughout the day for the latest roundup
- 3:52Speaker 2: of companies making news on Wall Street and for the
- 3:55Speaker 2: latest market moving headlines. Listen to Bloomberg Radio Live catches
- 3:59Speaker 2: on YouTube, Bloomberg dot com, and on Applecarplay and Android
- 4:03Speaker 2: Auto with the Bloomberg Business app. M